Imatinib (Gleevec®) as a paradigm of targeted cancer therapies

Brian Druker

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib (Gleevec®) as a paradigm of targeted cancer therapies'. Together they form a unique fingerprint.